e-learning
resources
Stockholm 2007
Monday 17.09.2007
Medical and surgical treatment of susceptible and resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcome of pulmonary multidrug-resistant tuberculosis
S. Toujani, J. Cherif, N. Mehiri, A. Zouaoui, B. Louzir, M. Beji (Tunis, Tunisia)
Source:
Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis
Session:
Medical and surgical treatment of susceptible and resistant tuberculosis
Session type:
Thematic Poster Session
Number:
2470
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Toujani, J. Cherif, N. Mehiri, A. Zouaoui, B. Louzir, M. Beji (Tunis, Tunisia). Outcome of pulmonary multidrug-resistant tuberculosis. Eur Respir J 2007; 30: Suppl. 51, 2470
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Treatment results of multidrug-resistant pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 11s
Year: 2006
Outcome of multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Surgical approach to multidrug-resistant pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 323s
Year: 2003
Value of surgery for multidrug-resistant pulmonary tuberculosis in Hungary
Source: Eur Respir J 2006; 28: Suppl. 50, 135s
Year: 2006
Evaluation of treatment outcomes for multidrug-resistant tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001
Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
Predictors of treatment outcome in multidrug-resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Diagnosis of COPD in patients with multidrug-resistant tuberculosis
Source: International Congress 2018 – COPD around the world
Year: 2018
Comorbidome in multidrug-resistant tuberculosis patients
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Management of MDR tuberculosis
Source: Short video discussion 2021
Year: 2021
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients
Source: Eur Respir J, 54 (1) 1800353; 10.1183/13993003.00353-2018
Year: 2019
Intravenous ozon in MDR pulmonary tuberculosis
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Effectiveness of thoracoplasty at disseminated drug-resistant fibrous-cavernous pulmonary tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010
Pulmonary tuberculosis
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Pulmonary tuberculosis
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Pulmonary tuberculosis
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Analysis of multidrug-resistant tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept